GSK Egypt to distribute EGP 0.75/share dividends

Updated 5/3/2023 1:13:00 PM
GSK Egypt to distribute EGP 0.75/share dividends

Arab Finance: GlaxoSmithKline’s (GSK – Egypt) (BIOC) ordinary general meeting (OGM) has approved the proposal of distributing cash dividends of EGP 0.75 per share to shareholders for 2022, according to a statement sent to the Egyptian Exchange (EGX) on May 3rd.

It is worth noting that GSK Egypt’s consolidated net profits after tax and non-controlling interest soared 375.6% year on year (YoY) to EGP 735.38 million in 2022, compared to EGP 154.64 million.

GSK Egypt, a member of the British pharmaceutical company Glaxo Group, is an Egypt-based company engaged in the manufacturing, packaging, marketing, selling, and distribution of pharmaceutical products.

Related News